Oracle to acquire Cerner for $28.3B ($95/sh); accretive to non-GAAP EPS in FY23

ORACLE CORP

All-cash tender offer at $95.00 per share, equity value ~$28.3B.
Expected to close in calendar 2022, subject to regulatory and tender conditions.
Accretive to Oracle's non-GAAP EPS in first full fiscal year after closing.
Cerner to operate as a dedicated Industry Business Unit within Oracle.
Oracle intends to retain an investment grade credit rating post-deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.